These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3311000)

  • 1. Membrane phospholipid metabolism during myocardial ischaemia: past, present and future.
    Sen A; Buja LM; Willerson JT; Chien KR
    Basic Res Cardiol; 1987; 82 Suppl 1():121-5. PubMed ID: 3311000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane phospholipids and plasmalogens in the ischemic myocardium.
    Kako KJ
    Can J Cardiol; 1986; 2(3):184-94. PubMed ID: 2424580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amiodarone therapy on the time course of myocardial phospholipid hydrolysis during in vitro total ischaemia in cat hearts.
    Shaikh NA
    J Mol Cell Cardiol; 1992 May; 24(5):507-21. PubMed ID: 1635074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion. Correlation with the progression of cell injury.
    Chien KR; Sen A; Reynolds R; Chang A; Kim Y; Gunn MD; Buja LM; Willerson JT
    J Clin Invest; 1985 Jun; 75(6):1770-80. PubMed ID: 3924955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of unesterified arachidonic acid in ischemic canine myocardium. Relationship to a phosphatidylcholine deacylation-reacylation cycle and the depletion of membrane phospholipids.
    Chien KR; Han A; Sen A; Buja LM; Willerson JT
    Circ Res; 1984 Mar; 54(3):313-22. PubMed ID: 6421507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipid alterations and membrane injury during myocardial ischemia.
    Chien KR; Willerson JT; Buja LM
    Adv Myocardiol; 1985; 5():347-53. PubMed ID: 3881812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.
    Farooqui AA; Rapoport SI; Horrocks LA
    Neurochem Res; 1997 Apr; 22(4):523-7. PubMed ID: 9130265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of ATP depletion on the action of phospholipase C on cardiac myocyte membrane phospholipids.
    Higgins TJ; Bailey PJ; Allsopp D
    J Mol Cell Cardiol; 1981 Nov; 13(11):1027-30. PubMed ID: 7321048
    [No Abstract]   [Full Text] [Related]  

  • 9. Alterations in phospholipid metabolism in the globally ischemic rat heart: emphasis on phosphoinositide specific phospholipase C activity.
    Schwertz DW; Halverson J; Isaacson T; Feinberg H; Palmer JW
    J Mol Cell Cardiol; 1987 Jul; 19(7):685-97. PubMed ID: 2824796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective hydrolysis of plasmalogen phospholipids by Ca2+-independent PLA2 in hypoxic ventricular myocytes.
    McHowat J; Liu S; Creer MH
    Am J Physiol; 1998 Jun; 274(6):C1727-37. PubMed ID: 9611139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of iron on membrane phospholipid breakdown in ischemic-reperfused rat heart.
    Liu XK; Prasad MR; Engelman RM; Jones RM; Das DK
    Am J Physiol; 1990 Oct; 259(4 Pt 2):H1101-7. PubMed ID: 2221118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial phospholipid composition and microviscosity in myocardial ischaemia.
    Victor T; van der Merwe N; Benade AJ; La Cock C; Lochner A
    Biochim Biophys Acta; 1985 Apr; 834(2):215-23. PubMed ID: 3995062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase A2-mediated hydrolysis of cardiac phospholipids: the use of molecular and transgenic techniques.
    De Windt LJ; Reneman RS; Van der Vusse GJ; Van Bilsen M
    Mol Cell Biochem; 1998 Mar; 180(1-2):65-73. PubMed ID: 9546632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of membrane phospholipid degradation in ischemic-reperfused rat hearts.
    Otani H; Prasad MR; Jones RM; Das DK
    Am J Physiol; 1989 Jul; 257(1 Pt 2):H252-8. PubMed ID: 2502030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of membrane phospholipid metabolism in heart cell culture.
    Freyss-Beguin MM; Millanvoye-Van Brussel EM; Simon JM; Duval DP
    Kidney Int Suppl; 1992 Jun; 37():S79-86. PubMed ID: 1630076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phospholipid alteration and activation of phospholipase A2 in ischemic heart].
    Yanoshita R
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):435-9. PubMed ID: 2024024
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion.
    Das DK; Engelman RM; Rousou JA; Breyer RH; Otani H; Lemeshow S
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H71-9. PubMed ID: 2942042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of phospholipids in ischemic canine myocardium during acute arrhythmia.
    Man RY; Slater TL; Pelletier MP; Choy PC
    Lipids; 1983 Oct; 18(10):677-81. PubMed ID: 6656533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Ca-independent PLA(2) and conservation of plasmalogen polyunsaturated fatty acids in diabetic heart.
    McHowat J; Creer MH; Hicks KK; Jones JH; McCrory R; Kennedy RH
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E25-32. PubMed ID: 10893319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol and myocardial membrane function.
    van der Laarse A
    Basic Res Cardiol; 1987; 82 Suppl 1():137-45. PubMed ID: 3311001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.